EMBC 15.54 (+1.64%)
US29082K1051Drug ManufacturersDrug Manufacturers - Specialty & Generic

Embecta (EMBC) Competitor Comparison

We are evaluating the key criteria listed to compare Embecta (EMBC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Dividend Rank - EMBC ranking 2 / 54

These are the competitors of Embecta in the industry Drug Manufacturers - Specialty & Generic ranked by dividend rank
1. Phibro Animal Health PAHC
0.36
2. Embecta EMBC
0.36
3. ProPhase Labs PRPH
0.29
4. Zoetis ZTS
0.29
5. Cumberland Pharmaceuticals CPIX
0.21
6. Linc LNC
0.21
7. Regencell Bioscience Holdings RGC
0.14
8. Perrigo PRGO
0.07
9. Amneal Pharmaceuticals AMRX
0.07
10. Taro Pharmaceutical Industries TARO
0.07
11. Supernus Pharmaceuticals SUPN
0.07
12. Vifor Pharma G2AB.F
0.07
13. Collegium Pharmaceutical COLL
0.07
14. Organogenesis Holdings ORGO
0.07
15. Eagle Pharmaceuticals EGRX
0
16. Elanco Animal Health ELAN
0
17. Emergent BioSolutions EBS
0
18. Evolus EOLS
0
19. Flora Growth FLGC
0
20. Green Thumb Industries R9U2.F
0
21. Harrow Health HROW
0
22. Ironwood Pharmaceuticals IRWD
0
23. Journey Medical DERM
0
24. Jupiter Wellness JUPW
0
25. Kamada KMDA
0
26. Kolinpharma KIP.MI
0
27. Neoleukin Therapeutics NLTX
0
28. OptiNose OPTN
0
29. Pacira BioSciences PCRX
0
30. PetIQ PETQ
0
31. Procaps Group PROC
0
32. Relmada Therapeutics RLMD
0
33. SCYNEXIS SCYX
0
34. Societal CDMO SCTL
0
35. Solid Biosciences SLDB
0
36. Teva Pharmaceutical Industries TEVA
0
37. Theratechnologies THTX
0
38. Tilray Brands TLRY
0
39. Universe Pharmaceuticals UPC
0
40. Alimera Sciences ALIM
0
41. Zynerba Pharmaceuticals ZYNE
0
42. Alpha Teknova TKNO
0
43. Alvotech ALVO
0
44. Amphastar Pharmaceuticals AMPH
0
45. ANI Pharmaceuticals ANIP
0
46. Ascend Wellness Holdings AAWH
0
47. Avadel Pharmaceuticals AVDL
0
48. Ayr Wellness 3KJB.F
0
49. Bausch Health Companies BHC
0
50. Biofrontera BFRI
0
51. Catalent CTLT
0
52. Clever Leaves Holdings CLVR
0
53. Cronos Group CRON
0
54. Curaleaf Holdings CURLF
0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.